A Phase 2 Dose Response Study of LY2484595 in Japanese Subjects

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080221488

Enrollment

Unknown

Registered

2011-06-22

Start date

2011-06-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dyslipidemias

Interventions

investigational material(s) Generic name etc : LY2484595 INN of investigational material : Therapeutic category code : 218 Agents for hyperlipidemias Dosage and Administration for Investigational mat

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Subjects are man or women >20 years of age, who have low HDL-C or high LDL-C without clinical manifestation of coronary heart disease.

Exclusion criteria

Exclusion criteria:

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026